Gas-liquid interface of intestinal bubbles

The **gas-liquid interface of intestinal bubbles** refers to the physical boundary between gaseous content and liquid (or semi-liquid) intestinal matter in the gastrointestinal tract. This interface is not a discrete molecular entity, but rather a physicochemical phenomenon relevant in contexts such as digestive physiology, medical imaging, and bioeffects of medical ultrasound. For example, cavitation at gas-liquid interfaces in the intestine can cause tissue injury under certain conditions (e.g., exposure to lithotripter shockwaves), and gas bubbles can create artifacts in CT imaging. Certain drugs, such as simethicone and dimethicone, are designed to alter the surface tension at these interfaces to promote bubble coalescence and alleviate symptoms of gas, but these drugs do not act on a discrete molecular target as traditionally defined in pharmacology. In summary, "gas-liquid interface of intestinal bubbles" is a physical property/structure, not a molecular target, so most canonical target fields do not apply. This entry would be flagged for correction in any pharmaceutical target database.

Other names

Gas-liquid interfaceIntestinal gas bubbles interface

Physical disruption or coalescence of gas bubbles (via surface tension modulation)